These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 704465)

  • 1. [Effectiveness, toxicity and action of new hypoglycemic agents].
    Wójcikowski C
    Pol Tyg Lek; 1978 Oct; 33(40):1583-4. PubMed ID: 704465
    [No Abstract]   [Full Text] [Related]  

  • 2. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoglycaemic and related activities of a new pyrazolopyridine derivative (SQ 65,993).
    Polacek I; Schulze E; Burg H; Ouart J
    Arzneimittelforschung; 1974 Sep; 24(9):1242-7. PubMed ID: 4479785
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
    D'Alò G; Dalla Vedova R; Cadel S; Campi G; Wassermann A
    Boll Chim Farm; 1978 Jun; 117(6):348-67. PubMed ID: 743381
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of hypoglycemic sulfonylurea preparations on the heart conduction system].
    Pogátsa G; Németh M
    Orv Hetil; 1980 Sep; 121(37):2255-7. PubMed ID: 6780962
    [No Abstract]   [Full Text] [Related]  

  • 7. [The chemotherapeutic use of antidiabetics. Sulfonylurea compounds and glinides].
    Mark M
    Pharm Unserer Zeit; 2002; 31(3):252-62. PubMed ID: 12071122
    [No Abstract]   [Full Text] [Related]  

  • 8. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of SPC-703 on blood pressure in rabbits and rats and on isolated heart of guinea pigs.
    Matuszek M; Gagało I; Hać E
    Pol J Pharmacol Pharm; 1979; 31(5):455-9. PubMed ID: 547276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 11. Actual problems of the hypoglycaemic sulfonylureas.
    Káldor A
    Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sulfonylureas and diabetes mellitus].
    Ascaso JF
    Med Clin (Barc); 1983 Sep; 81(7):302-4. PubMed ID: 6645672
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of oral hypoglycemic agents.
    Hagg SA
    Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
    Davidoff F
    R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
    [No Abstract]   [Full Text] [Related]  

  • 17. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-diabetic agents.
    Biron CR
    RDH; 1995 May; 15(5):32-4. PubMed ID: 10332415
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfonylureas: background and development of the field.
    Levine R
    Diabetes Care; 1984; 7 Suppl 1():3-7. PubMed ID: 6376027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.